Skip to content
GLP-1 Scorecard
Menu

Head-to-head · WeighScore

FlyteHealth vs The Virtual NP

FlyteHealth
Graded #363

Lower grade

vs+2.1999999999999957
The Virtual NP
Graded #316

Higher grade

The verdict

The Virtual NP takes it — 60.8/100 to 58.6/100.

The Virtual NP grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. The Virtual NP is a nurse-practitioner-led telehealth weight loss clinic prescribing FDA-approved branded GLP-1 medications, Zepbound (tirzepatide) and Wegovy (semaglutide), from Eli Lilly and Novo Nordisk.

We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.

Factor by factor

The same six graded dimensions, side by side. See the methodology.

Cost valueEven
45
45
Dose & formulationThe Virtual NP +13
40
53
Clinical oversightThe Virtual NP +11
83
94
Labs & monitoringFlyteHealth +19
73
54
FulfillmentThe Virtual NP +2
62
64
Contract termsEven
55
55
FlyteHealth · left barThe Virtual NP · right bar

The numbers

MetricFlyteHealthThe Virtual NP
WeighScore58.6/10060.8/100
GradeCC
Scorecard rank#363#316
SemaglutideNot disclosedNot disclosed
TirzepatideNot disclosedNot disclosed
CoverageCoverage not published7 states
Brand-name accessCompounded onlyYes
Oral / sublingualInjection onlyInjection only
FlyteHealth

Graded #363 · C

Strengths

  • Care led by board-certified obesity-medicine physicians
  • Multidisciplinary team with NPs, dietitians, and care coordinators
  • Published outcomes of about 13 to 16 percent weight loss over 12 months
  • High GLP-1 medication adherence (around 86 percent in reported data)
  • Comprehensive cardiometabolic care beyond GLP-1 alone

Where it loses points

  • Distributed primarily via employers, payers, and health plans, not direct cash-pay
  • Access is largely gated behind employer or plan sponsorship
  • GLP-1 is prescribed only when appropriate, not guaranteed
  • Self-pay pricing is not publicly listed (contact required)
  • Less suited to consumers wanting fast direct-to-door GLP-1
The Virtual NP

Graded #316 · C

Strengths

  • FDA-approved branded Zepbound and Wegovy only, no compounded
  • Transparent fees: 99 visit or 75 per month membership
  • HSA/FSA accepted and prior authorization assistance offered
  • NP-led with same or next-day booking and home shipping

Where it loses points

  • Branded only, so medication cost is high and billed separately
  • Limited to seven states
  • No compounded lower-cost GLP-1 alternative
  • Single-provider practice may limit scale and hours

Also worth a look

Neither is our top-graded pick — CoreAge Rx leads the scorecard

Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.

Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.

← Back to the scorecard